A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19683876

Int. J. Radiat. Oncol. Biol. Phys. 2010 May 1 77 1 92-7

Download in:

View as

Triples

General Info

PMID
19683876